1. From the Hematology/Oncology Division, Harvard Institute of Medicine, Harvard Medical School, and the Hematology/Oncology Division, Children's Hospital and the Dana Farber Cancer Institute, the Department of Pediatrics, Harvard Medical School, Howard Hughes Medical Institute, Boston, MA; and the Department of Immunology and Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA.